Yüklüyor......
Potential Cost Implications for All US Food and Drug Administration Oncology Drug Approvals in 2018
IMPORTANCE: The growth of cancer drug spending in the US has outpaced spending in nearly all other sectors, and an increasing proportion of the drug development pipeline is devoted to oncology. In 2018, there was a record number of drugs entering the US market. OBJECTIVE: To estimate the number of p...
Kaydedildi:
| Yayımlandı: | JAMA Intern Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Medical Association
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7653539/ https://ncbi.nlm.nih.gov/pubmed/33165499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2020.5921 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|